We are live on ! Find out more
COLL icon

Collegium Pharmaceutical

88 hedge funds and large institutions have $363M invested in Collegium Pharmaceutical in 2016 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 45 increasing their positions, 8 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

567% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 3

463% more repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 8

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

81.46% more ownership

Funds ownership: 0%81.46% (+81%)

24% more funds holding

Funds holding: 7188 (+17)

19% more capital invested

Capital invested by funds: $305M → $363M (+$58M)

69% less call options, than puts

Call options by funds: $238K | Put options by funds: $779K

Holders
88
Holders Change
+17
Holders Change %
+23.94%
% of All Funds
2.2%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
20
Increased
45
Reduced
8
Closed
3
Calls
$238K
Puts
$779K
Net Calls
-$541K
Net Calls Change
+$364K
Name Holding Trade Value Shares
Change
Change in
Stake
MCM
26
Moore Capital Management
New York
$1.95M +$2.08M +125,000 New
LPL Financial
27
LPL Financial
California
$1.86M -$6.12K -368 -0.3%
Morgan Stanley
28
Morgan Stanley
New York
$1.76M +$1.75M +105,080 +1,360%
Deutsche Bank
29
Deutsche Bank
Germany
$1.64M -$299K -17,966 -15%
TAM
30
Tocqueville Asset Management
New York
$1.21M +$450K +27,100 +53%
JG
31
Jefferies Group
New York
$1.18M +$1.26M +75,811 New
RJA
32
Raymond James & Associates
Florida
$1.03M -$92.2K -5,550 -8%
Bank of New York Mellon
33
Bank of New York Mellon
New York
$958K +$160K +9,630 +19%
NC
34
NBW Capital
Massachusetts
$948K -$14K -843 -1%
BIM
35
BlackRock Investment Management
Delaware
$913K +$119K +7,140 +14%
Charles Schwab
36
Charles Schwab
California
$702K +$394K +23,700 +111%
TCIM
37
TIAA CREF Investment Management
New York
$685K +$20.5K +1,234 +3%
Goldman Sachs
38
Goldman Sachs
New York
$555K +$401K +24,100 +209%
California State Teachers Retirement System (CalSTRS)
39
California State Teachers Retirement System (CalSTRS)
California
$529K +$88.1K +5,300 +18%
Swiss National Bank
40
Swiss National Bank
Switzerland
$472K +$206K +12,400 +69%
Norges Bank
41
Norges Bank
Norway
$467K +$499K +30,000 New
M&T Bank
42
M&T Bank
New York
$442K +$189K +11,373 +67%
Point72 Asset Management
43
Point72 Asset Management
Connecticut
$436K +$465K +28,000 New
Millennium Management
44
Millennium Management
New York
$411K +$438K +26,368 New
TA
45
Teachers Advisors
New York
$396K +$64.7K +3,892 +18%
Susquehanna International Group
46
Susquehanna International Group
Pennsylvania
$371K +$396K +23,830 New
PIM
47
Partner Investment Management
California
$370K +$276K +16,616 +232%
TC
48
TFS Capital
Pennsylvania
$352K -$188K -11,334 -33%
ProShare Advisors
49
ProShare Advisors
Maryland
$335K +$89.3K +5,371 +33%
Royal Bank of Canada
50
Royal Bank of Canada
Ontario, Canada
$312K +$78.4K +4,720 +31%

COLL Hedge Fund Activity: Q4 2016 in Review

88 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Collegium Pharmaceutical (COLL) for Q4 2016, worth a combined $363M — up 19% from $305M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new COLL positions and 3 closed out — a net gain of 17 holders — while 45 added to existing stakes and 8 trimmed.

The largest buyer was Sectoral Asset Management, adding an estimated $23.2M. The largest seller was Massachusetts Financial Services, cutting an estimated $995K.

  • 88 institutional investors held Collegium Pharmaceutical (COLL) as of Q4 2016, up from 71 in Q3 2016.
  • Funds reported $363M of Collegium Pharmaceutical stock for Q4 2016, up 19% quarter-over-quarter.
  • 20 funds opened new Collegium Pharmaceutical positions in Q4 2016 and 3 closed out, a net change of +17 holders.
  • The largest Collegium Pharmaceutical buyer in Q4 2016 was Sectoral Asset Management, an estimated $23.2M added.
  • The largest Collegium Pharmaceutical seller in Q4 2016 was Massachusetts Financial Services, an estimated $995K sold.

Based on aggregated 13F filings for Q4 2016.